These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10417291)

  • 1. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs.
    Zhu G; Duffy DL; Eldridge A; Grace M; Mayne C; O'Gorman L; Aitken JF; Neale MC; Hayward NK; Green AC; Martin NG
    Am J Hum Genet; 1999 Aug; 65(2):483-92. PubMed ID: 10417291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twins.
    Barrett JH; Gaut R; Wachsmuth R; Bishop JA; Bishop DT
    Br J Cancer; 2003 Jun; 88(12):1920-4. PubMed ID: 12799637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions.
    Zhu G; Montgomery GW; James MR; Trent JM; Hayward NK; Martin NG; Duffy DL
    Eur J Hum Genet; 2007 Jan; 15(1):94-102. PubMed ID: 17063143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
    Bishop JA; Wachsmuth RC; Harland M; Bataille V; Pinney E; MacK P; Baglietto L; Cuzick J; Bishop DT
    J Invest Dermatol; 2000 Jan; 114(1):28-33. PubMed ID: 10620111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles.
    Bataille V; Snieder H; MacGregor AJ; Sasieni P; Spector TD
    J Natl Cancer Inst; 2000 Mar; 92(6):457-63. PubMed ID: 10716963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage and association analysis of radiation damage repair genes XRCC3 and XRCC5 with nevus density in adolescent twins.
    Zhu G; Duffy DL; Turner DR; Ewen KR; Montgomery GW; Martin NG
    Twin Res; 2003 Aug; 6(4):315-21. PubMed ID: 14511439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study.
    Wachsmuth RC; Gaut RM; Barrett JH; Saunders CL; Randerson-Moor JA; Eldridge A; Martin NG; Bishop TD; Newton Bishop JA
    J Invest Dermatol; 2001 Aug; 117(2):348-52. PubMed ID: 11511314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of familial cutaneous melanoma.
    Haluska FG; Hodi FS
    J Clin Oncol; 1998 Feb; 16(2):670-82. PubMed ID: 9469357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
    Wang H; Presland RB; Piepkorn M
    Arch Dermatol; 2005 Feb; 141(2):177-80. PubMed ID: 15724013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
    Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
    J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
    Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
    J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous melanoma arising in agminated melanocytic nevi: CDKN2A and CDK4 mutation screening.
    Rezze GG; Leon A; Silva DC; Neves RI; Molina GC; Carraro DM; Landman G; Duprat JP
    Acta Derm Venereol; 2012 Jan; 92(1):98-9. PubMed ID: 21710107
    [No Abstract]   [Full Text] [Related]  

  • 13. The genetics of hereditary melanoma and nevi. 1998 update.
    Greene MH
    Cancer; 1999 Dec; 86(11 Suppl):2464-77. PubMed ID: 10630172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families.
    de Snoo FA; Hottenga JJ; Gillanders EM; Sandkuijl LA; Jones MP; Bergman W; van der Drift C; van Leeuwen I; van Mourik L; Huurne JA; Frants RR; Willemze R; Breuning MH; Trent JM; Gruis NA
    Eur J Hum Genet; 2008 Sep; 16(9):1135-41. PubMed ID: 18398432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
    Goldstein AM; Martinez M; Tucker MA; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of genetic and epigenetic changes in CDKN2A in melanocytic nevi.
    Welch J; Millar D; Goldman A; Heenan P; Stark M; Eldon M; Clark S; Martin NG; Hayward NK
    J Invest Dermatol; 2001 Aug; 117(2):383-4. PubMed ID: 11511321
    [No Abstract]   [Full Text] [Related]  

  • 17. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.
    Clark WH; Reimer RR; Greene M; Ainsworth AM; Mastrangelo MJ
    Arch Dermatol; 1978 May; 114(5):732-8. PubMed ID: 646394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From gene to disease; from p16 to melanoma].
    Gruis NA; Bergman W
    Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF polymorphisms and risk of melanocytic neoplasia.
    James MR; Roth RB; Shi MM; Kammerer S; Nelson MR; Stark MS; Dumenil T; Montgomery GW; Hayward NK; Martin NG; Braun A; Duffy DL
    J Invest Dermatol; 2005 Dec; 125(6):1252-8. PubMed ID: 16354196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
    Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U
    J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.